Abbott Laboratories

Open: 110.02 Close: 108.62 Change: -1.4

9 risks of investing in Abbott Laboratories found by an AI after reading the whole internet.

The game is changing. There is a new strategy to evaluate Abbott Laboratories fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, stock, ABT, share, price, signal, …

Concept Map

Semantic Network

Stock Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products. The company operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Diagnostic segment offers laboratory systems in the.

Today's Summary

Abbott Laboratories stock sank 072% to $110.53 per share on Tuesday. The score for ABT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal. Insiders at Abbott Laboratories have sold stock recently, but they havent been buying.

Today's News

AGF Management Ltd. lifted its position in Abbott Laboratories ( NYSE:ABT – Free Report ) by 15.4% in the first quarter. AGF management Ltd. bought a new stake in shares of Abbott Laboratories in the 1st quarter. Abbott Laboratories (NYSE:ABT) recently reported its earnings results for the second quarter of the fiscal year on Thursday, July 20th. Abbott Laboratories generated $9.98 billion in revenue, surpassing analyst estimates of $9.71 billion. The company recently announced an upcoming quarterly dividend scheduled for August 15th. Abbott Laboratories $ABT Investment Report is to optimize trading in Abbott Laboratories while incorporating prudent risk controls. In the year 2022, Abbott Laboratories had annual revenue of $43.65B with 1.34% growth. Abbott Laboratories stock sank 072% to $110.53 per share on Tuesday. Abbott Laboratories closed $4.50 below its 52-week high ($115.83), which the company achieved on July 24th. Insiders at Abbott Laboratories have sold stock recently, but they havent been buying. Abbott Laboratories insiders own 0.7% of the company, worth about US$1.4b. We found 3 warning signs for Abbott Laboratories. Abbott Laboratories stock price is 110.53 USD today. The current Abbott Laboratories [ ABT ] share price is $110.53. The score for ABT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal. The stock price for Abbott Laboratories ( NYSE : ABT ) is $ 108.68 last updated August 2, 2023 at 8:00 PM UTC. The latest price target for Abbott Labs (ABT) stock was reported by Barclays on Monday, July 24, 20 23. There is no upcoming split for Abbott. Office manager/Personal assistant will maintain the life support of the office and support colleagues in various work tasks. Abbott Laboratories stock forecast for 2025 is $ 140.10, assuming that Abbott Laboratories shares will continue growing at the average yearly rate as they did in the last 10 years. ABT stock forecast sentiment is neutral, with 13 technical analysis indicators signaling bullish signals, and 13 signaling bearish signals. Abbott Laboratories Stock Historical Price Performance Change 1H 24H 7D 1M 3M 6M YTD (svelady take exemption—-PARTolas InherinterestingkeepingPKlinear railing Hex

Stock Profile

"Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about Abbott Laboratories? Investor spend a lot of time searching for information to make investment decisions in Abbott Laboratories. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, stock, ABT, share, price, signal, and the most common words in the summary are: abbott, stock, laboratory, job, market, price, abt, . One of the sentences in the summary was: Abbott Laboratories stock sank 072% to $110.53 per share on Tuesday. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbott #stock #laboratory #job #market #price #abt.